i-SENS, Inc. (KOSDAQ:099190)

South Korea flag South Korea · Delayed Price · Currency is KRW
16,550
+40 (0.24%)
Feb 21, 2025, 3:30 PM KST
-25.62%
Market Cap 457.41B
Revenue (ttm) 284.77B
Net Income (ttm) -1.83B
Shares Out 27.64M
EPS (ttm) -66.41
PE Ratio n/a
Forward PE 62.69
Dividend 100.00 (0.60%)
Ex-Dividend Date Dec 27, 2024
Volume 79,153
Average Volume 131,527
Open 16,510
Previous Close 16,510
Day's Range 16,310 - 16,670
52-Week Range 14,520 - 23,000
Beta 0.79
RSI 41.86
Earnings Date Mar 20, 2025

About i-SENS

i-SENS, Inc. engages in the development, manufacture, and sale of chemical and biosensors in South Korea and internationally. The company offers blood glucose monitoring devices; diabetes care, acute care, and coagulation care devices; veterinary care devices; and accessory products. It also provides SmartLog, a diabetes management software for mobile and PC. The company was founded in 2000 and is headquartered in Seoul, South Korea. [Read more]

Industry Medical - Specialties
Sector Healthcare
Founded 2000
Employees 845
Stock Exchange KOSDAQ
Ticker Symbol 099190
Full Company Profile

Financial Performance

In 2023, i-SENS's revenue was 265.12 billion, an increase of 0.11% compared to the previous year's 264.84 billion. Earnings were 3.71 billion, a decrease of -77.02%.

Financial Statements

News

There is no news available yet.